Last reviewed · How we verify
GBR 830
At a glance
| Generic name | GBR 830 |
|---|---|
| Sponsor | Ichnos Sciences SA |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis (PHASE2)
- The Effectiveness of Physical Therapy Modalities in Carpal Tunnel Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GBR 830 CI brief — competitive landscape report
- GBR 830 updates RSS · CI watch RSS
- Ichnos Sciences SA portfolio CI